Tumor cell contamination in ovarian tissue cryopreserved before gonadotoxic treatment: Should we systematically exclude ovarian autograft in a cancer survivor

Bone Marrow Transplantation

Volumn 45, Issue 7, 2010, Pages 1247-1248

  Courbiere, B ^a,b   Prebet, T ^b,c   Mozziconacci, M J ^c   Metzler Guillemain, C ^d   Saias Magnan, J ^b,d   Gamerre, M ^a,b  

^a APHM Hpital la Conception   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c INSTITUT PAOLI CALMETTES   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; IMATINIB; ANTINEOPLASTIC AGENT;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER SURVIVOR; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CONTAMINATION; CRYOPRESERVATION; CYTOGENETICS; CYTOLOGY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; LETTER; MYELOABLATIVE CONDITIONING; OVARIAN PRESERVATION; OVARIECTOMY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; ADOLESCENT; COMPLICATION; DRUG EFFECTS; FERTILITY; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; OVARY; TOXICITY; TRANSPLANTATION;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CRYOPRESERVATION; FEMALE; FERTILITY; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; OVARY;

EID: 77955014043     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.313     Document Type: Letter

References (9)

1. Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Orthotopic and heterotopic ovarian tissue transplantation. Hum Reprod Update 2009; 15: 649-665.
2. Meirow D, Ben Yehuda D, Prus D, Poliack A, Schenker JG, Rachmilewitz EA et al. Ovarian tissue banking in patients with Hodgkin's disease: is it safe? Fertil Steril 1998; 69: 996-998.
3. Goldman JM. How I treat chronic myeloid leukemia in the imatinib era. Blood 2007; 110: 2828-2837.
4. Courbiere B, Agostini A, Cravello L, Gamerre M. How to perform. an ovariectomy for ovarian cryopreservation in the aim of an orthotopic ovarian autograft. Gynecol Obstet Fertil 2007; 35: 684-685.
5. Colle I, Lacor P, Peeters P, Jochmans K, De Raeve H, Van Camp B. Granulocytic sarcoma (chloroma): a report of two cases. Acta Clin Belg 1996; 51: 106-110.
6. Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra'anani H et al. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 2008; 23: 1007-1013.
7. Shaw JM, Bowles J, Koopman P, Wood EC, Trounson AO. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod 1996; 11: 1668-1673.
8. Kim SS, Radford J, Harris M, Varley J, Rutherford AJ, Lieberman B et al. Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum Reprod 2001; 16: 2056-2060.
9. Schmitz N, Buske C, Gisselbrecht C. Autologous stem cell transplantation in lymphoma. Semin Hematol 2007; 44: 234-245.